Cohort Study on the Prognosis and Influencing Factors in Elderly Patients With Hip Fractures in Multicenter of China
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorBeijing Hospital
About this trial
To address the difficulties and problems currently facing large-scale clinical cohort studies in China, and on the basis of the existing project "Construction of Clinical Registration Database and Risk Assessment System for Osteoporosis and Osteoarthritis" under the National Key R\&D Program of the Ministry of Science and Technology, this project aims to target elderly hip fracture-an international public health issue-by collaborating with 38 hospitals across the country to jointly establish the largest specialized cohort for elderly hip fracture in China, thereby providing a data platform and technical support for multicenter clinical cohort studies on elderly hip fracture.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Hip fracture inpatients at grade-A tertiary hospitals across China
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
10,000 Participants
are grouped into 1 trial groupGroup A: A cohort of elderly patients with hip fracture
Trial outcomes
Primary outcomes
1
death
Post-hip fracture mortality (yes/no)
Time frame
Six months, one year, and two years after hip fractureSecondary outcomes
1
Clavien-Dindo classification of complications
Clavien-Dindo classification of complications
Time frame
Six months, one year, and two years after hip fracture2
Conservative treatment status for patients managed non-surgically
Conservative treatment status for patients managed non-surgically
Time frame
Six months, one year, and two years after hip fracture3
Imaging data
Imaging data
Time frame
one day，Six months, one year, and two years after hip fracture4
Other new adverse events
Other new adverse events
Time frame
Six months, one year, and two years after hip fractureSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov